CEL-SCI prices $5M public offering at 31c per share
PremiumThe FlyCEL-SCI prices $5M public offering at 31c per share
3M ago
CEL-SCI announces common stock offering, no amount given
Premium
The Fly
CEL-SCI announces common stock offering, no amount given
3M ago
CEL-SCI provides rationale for use of Multikine in head, neck cancer study
Premium
The Fly
CEL-SCI provides rationale for use of Multikine in head, neck cancer study
4M ago
CEL-SCI reports new data from Multikine study
PremiumThe FlyCEL-SCI reports new data from Multikine study
7M ago
Cel Sci options imply 19.3% move in share price post-earnings
Premium
The Fly
Cel Sci options imply 19.3% move in share price post-earnings
8M ago
3 Penny Stocks to Watch Now, 7/30/24
Premium
Market News
3 Penny Stocks to Watch Now, 7/30/24
8M ago
CEL-SCI reports results from Multikine bias analysis
PremiumThe FlyCEL-SCI reports results from Multikine bias analysis
8M ago
CEL-SCI appoints Robert Watson as chairperson
Premium
The Fly
CEL-SCI appoints Robert Watson as chairperson
9M ago
CEL-SCI presents Head & Neck Cancer data at IDDST
Premium
The Fly
CEL-SCI presents Head & Neck Cancer data at IDDST
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100